SJM Brady MRI Post Approval Study

NCT ID: NCT03170583

Last Updated: 2020-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

1768 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-08

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System) in subjects with a standard bradycardia pacing indication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multi-center clinical study designed to evaluate the long-term safety of the Tendril MRI™ lead implanted with any SJM Brady MRI pacemaker or similar model (SJM Brady MRI system) in subjects with a standard bradycardia pacing indication through 60 months of follow up.

Additionally, the study will assess the safety of the pacemaker system in subject(s) undergoing clinically indicated MRI scan(s). Any enrolled subject implanted with the SJM Brady MRI system may be included in this evaluation if they are scheduled for or planning to have a MRI scan during the course of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bradycardia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

St. Jude Medical Tendril MRI™ lead

pacemaker, leads

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

St. Jude Medical Accent MRI™ pacemaker St. Jude Medical Assurity MRI™ pacemaker St. Jude Medical Endurity MRI™pacemaker

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is able to provide informed consent for study participation (legally authorized representative is NOT acceptable).
2. Subject is at least 18 years of age or of legal age to give informed consent specific to state and national law.
3. Subject meets at least one of the following criteria:

1. Is an Accent MRI IDE study subject who is being rolled over into the SJM Brady MRI PAS and still has at least one Tendril MRI™ lead implanted with a SJM Brady MRI pacemaker such as the Accent MRI or similar model.
2. Is a subject who has been implanted with at least one Tendril MRI lead and a SJM Brady MRI pacemaker such as the Accent MRI or similar model, but is not part of the Accent MRI IDE study and will be enrolled within 30 days after implant.
3. Is a subject who will be implanted with at least one Tendril MRI lead and a SJM Brady MRI pacemaker such as the Accent MRI or similar model and will be consented either at or within 30 days before implant.
4. Subject is willing and able to comply with the prescribed follow-up tests and schedule of evaluations including MRI scan procedures.

Exclusion Criteria

1. Subject has been enrolled or intends to participate in a clinical drug and/or device study with an active treatment arm or that has any procedures, which could confound the results of this trial.
2. Subject is not expected to be able to complete the study follow up schedule or duration due to any health condition such as has malignancy, is deemed a candidate for transplant or Ventricular Assist Device, or in hospice care.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Grant Kim, MS

Role: STUDY_DIRECTOR

Abbott (formerly St. Jude Medical)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Phoenix Cardiovascular Research Group

Phoenix, Arizona, United States

Site Status

Cardiology Associates of North East Arkansas

Jonesboro, Arkansas, United States

Site Status

Arkansas Heart Hospital

Little Rock, Arkansas, United States

Site Status

Mercy Hospital Northwest Arkansas

Rogers, Arkansas, United States

Site Status

Central Cardiology

Bakersfield, California, United States

Site Status

Raymond Schaerf, MD

Burbank, California, United States

Site Status

St. Helena Hospital

Deer Park, California, United States

Site Status

USC University Hospital

Los Angeles, California, United States

Site Status

Riverside Medical Clinic

Riverside, California, United States

Site Status

Sutter Medical Center, Sacramento

Sacramento, California, United States

Site Status

San Diego Heart Rhythm Center

San Diego, California, United States

Site Status

University of California at San Diego (UCSD) Medical Center

San Diego, California, United States

Site Status

Medical Specialists of the Palm Beaches

Atlantis, Florida, United States

Site Status

Bay Area Cardiology Associates PA

Brandon, Florida, United States

Site Status

Shands Jacksonville

Jacksonville, Florida, United States

Site Status

Hrachian Hakop MD PA

South Miami, Florida, United States

Site Status

Cardiology Partners

Wellington, Florida, United States

Site Status

Piedmont Athens Regional Medical Center

Athens, Georgia, United States

Site Status

Atlanta Heart Specialist

Cumming, Georgia, United States

Site Status

Coliseum Medical Centers

Macon, Georgia, United States

Site Status

University of Kentucky

Lexington, Kentucky, United States

Site Status

Ochsner Medical Center

New Orleans, Louisiana, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

McLaren Health Care Corporation

Auburn Hills, Michigan, United States

Site Status

Sparrow Clinical Research Institute

Lansing, Michigan, United States

Site Status

MidMichigan Medical Center-Midland

Midland, Michigan, United States

Site Status

Munson Medical Center

Traverse City, Michigan, United States

Site Status

Minneapolis Heart Institute

Minneapolis, Minnesota, United States

Site Status

Jackson Heart Clinic

Jackson, Mississippi, United States

Site Status

Missouri Heart Center

Columbia, Missouri, United States

Site Status

St. Luke's Hospital

Kansas City, Missouri, United States

Site Status

Missouri Baptist Medical Center

St Louis, Missouri, United States

Site Status

Kearney Regional Medical Center

Kearney, Nebraska, United States

Site Status

BryanLGH Medical Center East

Lincoln, Nebraska, United States

Site Status

Cardiovascular Associates of the Delaware Valley

Haddon Heights, New Jersey, United States

Site Status

Saint Barnabas Medical Center

Livingston, New Jersey, United States

Site Status

New Brunswick Cardiology Group

Somerset, New Jersey, United States

Site Status

New Mexico Heart Institute

Albuquerque, New Mexico, United States

Site Status

Capital Cardiology Associates

Albany, New York, United States

Site Status

New York Presbyterian Hospital/Cornell University

New York, New York, United States

Site Status

Hudson Valley Cardiovascular Practice, P.C.

Poughkeepsie, New York, United States

Site Status

Novant Health Heart and Vascular Research Institute

Charlotte, North Carolina, United States

Site Status

East Carolina Heart Institute

Greenville, North Carolina, United States

Site Status

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Ohio State University

Columbus, Ohio, United States

Site Status

The Toledo Hospital

Toledo, Ohio, United States

Site Status

Abington Medical Specialists

Abington, Pennsylvania, United States

Site Status

Pinnacle Health System

Harrisburg, Pennsylvania, United States

Site Status

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Donald Guthrie Foundation for Education and Research

Sayre, Pennsylvania, United States

Site Status

Trident Medical Center

Charleston, South Carolina, United States

Site Status

St. Francis Hospital

Greenville, South Carolina, United States

Site Status

Spartanburg Regional Medical Center

Spartanburg, South Carolina, United States

Site Status

Erlanger Medical Center

Chattanooga, Tennessee, United States

Site Status

The Stern Cardiovascular Foundation

Germantown, Tennessee, United States

Site Status

BCS Heart, LLP

College Station, Texas, United States

Site Status

Medical City Dallas Hospital

Dallas, Texas, United States

Site Status

Fort Worth Heart

Fort Worth, Texas, United States

Site Status

Houston Cardiovascular Associates

Houston, Texas, United States

Site Status

South Texas Cardiovascular Consultants

San Antonio, Texas, United States

Site Status

Carient Heart & Vascular, P.C.

Manassas, Virginia, United States

Site Status

Sentara Norfolk General Hospital

Norfolk, Virginia, United States

Site Status

Marshfield Clinic

Marshfield, Wisconsin, United States

Site Status

Aurora Medical Group

Milwaukee, Wisconsin, United States

Site Status

Aspirus Wausau Hospital

Wausau, Wisconsin, United States

Site Status

Cheyenne Cardiology Associates

Cheyenne, Wyoming, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SJM-CIP- CL1000304

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SureScan Post-Approval Study
NCT01299675 COMPLETED
China 3T MRI Study
NCT06038123 COMPLETED NA
One More Magnetic Resonance Imaging
NCT02293070 COMPLETED NA